Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

Table 3 Results of immunohistochemistry in individual patients with GBMO

patient no.	GFAP	Ki-67	p53	CD68
1	++	+	++	n. a.
2	+	+++	+	++
3	++	++	n. a.	+
4	n. a.	n. a.	n. a.	n. a.
5	++	+	n. a.	++
6	+	+++	n. a.	n. a.
7	+	++	+	++
8	+	++	+	++
9	++	+	n. a.	++
10	+	++	n. a.	n. a.

Results of immunohistochemistry for glial fibrillary acidic protein (GFAP), Ki-67, p53 and CD68 in individual patients with glioblastoma multiforme with oligodendroglial component (GBMO; patient numbers correspond to Table 2). Staining was scored as weak (+), intermediate (++), strong (+++) or not available (n.a.).

ISSN: 1471-2407